Adma Biologics, Inc.
ADMA· Nasdaq
Released Mar 29, 2018, after the close
10-K filed Mar 29, 2018, 88 days after period end · 0001193805-18-000470
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | $12.00M | $3.33M | $2.51M | $1.49M |
| Net Income | -$12.98M | -$4.56M |
Adma Biologics, Inc. · CIK 1368514 · Engraved from SEC EDGAR
| -$4.58M |
| -$3.56M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.